
Sign up to save your podcasts
Or
Cigna officially offloads its Medicare Advantage business to Health Care Service Corporation. The Biden Administration will negotiate on behalf of states to provide a groundbreaking gene therapy for Medicaid beneficiaries with sickle cell disease. And, the Dana Farber Cancer Institute is issuing corrections and retracting some research papers amid falsification allegations. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
4.8
134134 ratings
Cigna officially offloads its Medicare Advantage business to Health Care Service Corporation. The Biden Administration will negotiate on behalf of states to provide a groundbreaking gene therapy for Medicaid beneficiaries with sickle cell disease. And, the Dana Farber Cancer Institute is issuing corrections and retracting some research papers amid falsification allegations. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
902 Listeners
8,659 Listeners
1,014 Listeners
9,202 Listeners
86,708 Listeners
111,917 Listeners
478 Listeners
32,390 Listeners
1,083 Listeners
184 Listeners
6,447 Listeners
4,476 Listeners
391 Listeners
147 Listeners
15,321 Listeners